Trends in Radiation Therapy among Cancer Survivors in the United States, 2000-2030
Autor: | Matthew P. Banegas, Maria Elena Martinez, James D. Murphy, Alex K. Bryant, Loren K. Mell |
---|---|
Rok vydání: | 2017 |
Předmět: |
Oncology
Gerontology Male History Aging Colorectal cancer Epidemiology medicine.medical_treatment Medical and Health Sciences Prostate cancer 0302 clinical medicine Cancer Survivors 80 and over 030212 general & internal medicine Child Cancer Aged 80 and over education.field_of_study Incidence (epidemiology) Rehabilitation Middle Aged 21st Century humanities 030220 oncology & carcinogenesis Child Preschool population characteristics Female Patient Safety Adult medicine.medical_specialty Adolescent Population History 21st Century 03 medical and health sciences Young Adult Rare Diseases Internal medicine medicine Humans education Preschool Aged Radiotherapy business.industry Prevention Head and neck cancer Infant Newborn Infant social sciences medicine.disease Newborn United States Radiation therapy Good Health and Well Being business |
Zdroj: | Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, vol 26, iss 6 Bryant, AK; Banegas, MP; Martinez, ME; Mell, LK; & Murphy, JD. (2017). Trends in Radiation Therapy among Cancer Survivors in the United States, 2000-2030. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 26(6), 963-970. doi: 10.1158/1055-9965.EPI-16-1023. UC San Diego: Retrieved from: http://www.escholarship.org/uc/item/55f8884v |
Popis: | Background: Although the number of cancer survivors has increased substantially over the past several decades, the composition of survivors treated with radiotherapy is not well defined. Radiotherapy carries unique long-term toxicity risks for cancer survivors. This study describes the current estimates and future projections of the epidemiology of 5-year cancer survivors who receive radiation therapy. Methods: We used cancer incidence and survival data from the Surveillance, Epidemiology, and End-Results (SEER) database linked to U.S. Census data to estimate the number of 5-year cancer survivors treated with radiation between 2000 and 2030. Future projections assumed continuing incidence and survival trends based on historical rates. Results: In 2016, there were an estimated 3.05 million cancer survivors treated with radiation, accounting for 29% of all cancer survivors. The number of radiation-treated cancer survivors is projected to reach 3.38 million by 2020 and 4.17 million by 2030. In 2016, breast (40%) and prostate cancer (23%) composed the majority of radiation-treated survivors, followed by head and neck cancer (5.8%), lymphoma (5.6%), uterine (3.9%), and rectal cancer (3.8%). The percentage of 70 years or older radiation-treated survivors steadily increased between 2000 and 2030. Conclusions: The next several years are projected to see a large increase in the number of cancer survivors treated with radiation. Impact: This group of cancer survivors has unique needs given the long-term risks of radiation, and increased research and awareness are required to optimize health of this growing population. Cancer Epidemiol Biomarkers Prev; 26(6); 963–70. ©2017 AACR. |
Databáze: | OpenAIRE |
Externí odkaz: |